FindTrial
Sign In

The application of cardiac magnetic resonance in the diagnosis, risk stratification and prognosis of dilated cardiomyopathy

Application of cardiac magnetic resonance in the diagnosis, risk stratification and prognosis of dilated cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077615
Enrollment
Unknown
Registered
2023-11-14
Start date
2023-03-25
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dilated cardiomyopathy

Interventions

DCM group:None
Healthy control group:None

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Left ventricular or biventricular systolic dysfunction (defined as LVEF<45%) with ventricular dilatation, excluding diseases such as abnormal load and coronary artery stenosis.

Exclusion criteria

Exclusion criteria: 1) Congenital heart disease, valvular heart disease, ischemic heart disease and other diseases with cardiac enlargement were excluded; 2) Large image artifacts can interfere with the diagnosis; 3) Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
CMR cardiac function parameters ;Global and segmental ventricular strain;Atrial strain;—

Secondary

MeasureTime frame
General clinical information (laboratory examination, clinical medication history, electrocardiogram examination, ultrasound examination, etc.);—

Countries

China

Contacts

Public ContactLianggeng Gong

The Second Affiliated Hospital of Nanchang University

gong111999@126.com+86 139 7093 6212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026